去甲肾上腺素转运体抑制剂阿托西汀引起神经源性直立性低血压的升压反应的预测因素。
Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension.
机构信息
Vanderbilt Autonomic Dysfunction Center, Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (C.A.S., J.E.C., I.B.).
Dysautonomia Center, Department of Neurology, NYU Langone Medical Center, NY (J.-A.P., J.M., H.K.).
出版信息
Hypertension. 2021 Aug;78(2):525-531. doi: 10.1161/HYPERTENSIONAHA.119.14483. Epub 2021 Jun 28.
Abstract
[Figure: see text].
摘要
[图：见正文]。
相似文献
1
Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension.去甲肾上腺素转运体抑制剂阿托西汀引起神经源性直立性低血压的升压反应的预测因素。
Hypertension. 2021 Aug;78(2):525-531. doi: 10.1161/HYPERTENSIONAHA.119.14483. Epub 2021 Jun 28.
2
Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.托莫西汀与米多君治疗自主神经功能衰竭所致直立性低血压的疗效比较
Hypertension. 2014 Dec;64(6):1235-40. doi: 10.1161/HYPERTENSIONAHA.114.04225. Epub 2014 Sep 2.
3
Norepinephrine Reuptake Inhibition, an Emergent Treatment for Neurogenic Orthostatic Hypotension.去甲肾上腺素再摄取抑制，治疗神经源性直立性低血压的新方法。
Hypertension. 2024 Jul;81(7):1460-1466. doi: 10.1161/HYPERTENSIONAHA.124.22069. Epub 2024 May 20.
4
Multiple system atrophy: using clinical pharmacology to reveal pathophysiology.多系统萎缩：运用临床药理学揭示病理生理学
Clin Auton Res. 2015 Feb;25(1):53-9. doi: 10.1007/s10286-015-0271-4. Epub 2015 Mar 11.
5
Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in autonomic failure.去甲肾上腺素转运蛋白阻滞和α-2 拮抗作用对自主神经衰竭血压的协同作用。
Hypertension. 2012 Mar;59(3):650-6. doi: 10.1161/HYPERTENSIONAHA.111.184812. Epub 2012 Feb 6.
6
Cardiac ectopy in chronic autonomic failure.慢性自主神经衰竭中的心律失常。
Clin Auton Res. 2010 Apr;20(2):85-92. doi: 10.1007/s10286-009-0043-0. Epub 2009 Dec 11.
7
Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension.阿托西汀和吡啶斯的明在神经源性直立性低血压患者中的协同升压作用。
Hypertension. 2019 Jan;73(1):235-241. doi: 10.1161/HYPERTENSIONAHA.118.11790.
8
Orthostatic Hypotension: JACC State-of-the-Art Review.直立性低血压：JACC 最新综述
J Am Coll Cardiol. 2018 Sep 11;72(11):1294-1309. doi: 10.1016/j.jacc.2018.05.079.
9
L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.左旋二羟基苯丝氨酸（屈昔多巴）治疗直立性低血压：欧洲经验
Clin Auton Res. 2008 Mar;18 Suppl 1:25-9. doi: 10.1007/s10286-007-1005-z. Epub 2008 Mar 27.
10
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.左旋二羟基苯丝氨酸（屈昔多巴）：神经源性直立性低血压的一种新疗法：美国的经验
Clin Auton Res. 2008 Mar;18 Suppl 1:19-24. doi: 10.1007/s10286-007-1002-2. Epub 2008 Mar 27.
引用本文的文献
1
Intersection of Autonomic Dysfunction and Parkinson's Disease: Insights Into Neurogenic and Classical Orthostatic Hypotension.自主神经功能障碍与帕金森病的交集：对神经源性和经典体位性低血压的见解。
Cureus. 2025 Jul 22;17(7):e88487. doi: 10.7759/cureus.88487. eCollection 2025 Jul.
2
Orthostatic hypotension in Parkinson's disease: therapeutic considerations.帕金森病中的直立性低血压：治疗考量
Ther Adv Neurol Disord. 2025 Aug 19;18:17562864251363292. doi: 10.1177/17562864251363292. eCollection 2025.
3
A Case of Severe Advanced Diabetic Cardiac Autonomic Neuropathy: Severe Orthostatic Hypotension Complicated With Episodes of Nocturnal Supine Hypertensive Emergency Episodes.一例严重晚期糖尿病性心脏自主神经病变：严重直立性低血压合并夜间仰卧位高血压急症发作。
Cureus. 2024 Dec 5;16(12):e75153. doi: 10.7759/cureus.75153. eCollection 2024 Dec.
4
Oral blood pressure augmenting agents for intravenous vasopressor weaning.用于静脉血管加压药撤机的口服血压增强剂。
World J Clin Cases. 2024 Dec 26;12(36):6892-6904. doi: 10.12998/wjcc.v12.i36.6892.
5
Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review).帕金森病中的心血管自主神经功能障碍与认知障碍（综述）
Med Int (Lond). 2024 Sep 19;4(6):70. doi: 10.3892/mi.2024.194. eCollection 2024 Nov-Dec.
6
Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled crossover trial.托莫西汀治疗神经源性直立性低血压：一项随机、双盲、安慰剂对照交叉试验。
Clin Auton Res. 2024 Dec;34(6):561-569. doi: 10.1007/s10286-024-01051-2. Epub 2024 Sep 19.
7
Mast cell activation syndrome: An up-to-date review of literature.肥大细胞活化综合征：文献综述
World J Clin Pediatr. 2024 Jun 9;13(2):92813. doi: 10.5409/wjcp.v13.i2.92813.
8
Norepinephrine Reuptake Inhibition, an Emergent Treatment for Neurogenic Orthostatic Hypotension.去甲肾上腺素再摄取抑制，治疗神经源性直立性低血压的新方法。
Hypertension. 2024 Jul;81(7):1460-1466. doi: 10.1161/HYPERTENSIONAHA.124.22069. Epub 2024 May 20.
9
Effects of Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Alpha-synucleinopathies: A Systematic Review of Randomized Controlled Trials and a Focus-Group Discussion.托莫西汀治疗α-突触核蛋白病患者神经源性直立性低血压的疗效：随机对照试验的系统评价和焦点小组讨论
J Clin Neurol. 2023 Mar;19(2):165-173. doi: 10.3988/jcn.2022.0018. Epub 2023 Jan 2.
10
Updates on the Diagnosis and Treatment of Peripheral Autonomic Neuropathies.周围自主神经病的诊断与治疗进展。
Curr Neurol Neurosci Rep. 2022 Dec;22(12):823-837. doi: 10.1007/s11910-022-01240-4. Epub 2022 Nov 15.
本文引用的文献
1
Baroreflex Dysfunction.压力感受器反射功能障碍
N Engl J Med. 2020 Jan 9;382(2):163-178. doi: 10.1056/NEJMra1509723.
2
Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.卧位血浆去甲肾上腺素可预测神经源性直立性低血压患者对屈昔多巴的升压反应。
Neurology. 2018 Oct 16;91(16):e1539-e1544. doi: 10.1212/WNL.0000000000006369. Epub 2018 Sep 19.
3
The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.一个共识小组关于神经源性直立性低血压及相关卧位高血压的筛查、诊断和治疗的建议。
J Neurol. 2017 Aug;264(8):1567-1582. doi: 10.1007/s00415-016-8375-x. Epub 2017 Jan 3.
4
Multiple system atrophy: using clinical pharmacology to reveal pathophysiology.多系统萎缩：运用临床药理学揭示病理生理学
Clin Auton Res. 2015 Feb;25(1):53-9. doi: 10.1007/s10286-015-0271-4. Epub 2015 Mar 11.
5
Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.托莫西汀与米多君治疗自主神经功能衰竭所致直立性低血压的疗效比较
Hypertension. 2014 Dec;64(6):1235-40. doi: 10.1161/HYPERTENSIONAHA.114.04225. Epub 2014 Sep 2.
6
ASH position paper: evaluation and treatment of orthostatic hypotension.ASH 立场文件：直立性低血压的评估和治疗。
J Clin Hypertens (Greenwich). 2013 Mar;15(3):147-53. doi: 10.1111/jch.12062. Epub 2013 Jan 14.
7
Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach.哌甲酯、托莫西汀和安慰剂对健康志愿者静息时局部脑血流的分离作用：多类模式识别方法。
Neuroimage. 2012 Apr 2;60(2):1015-24. doi: 10.1016/j.neuroimage.2012.01.058. Epub 2012 Jan 14.
8
The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.直立性低血压问卷 (OHQ)：一种新型症状评估量表的验证。
Clin Auton Res. 2012 Apr;22(2):79-90. doi: 10.1007/s10286-011-0146-2. Epub 2011 Nov 2.
9
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.关于直立性低血压、神经介导性晕厥和体位性心动过速综合征定义的共识声明。
Auton Neurosci. 2011 Apr 26;161(1-2):46-8. doi: 10.1016/j.autneu.2011.02.004. Epub 2011 Mar 9.
10
Second consensus statement on the diagnosis of multiple system atrophy.关于多系统萎缩诊断的第二篇共识声明。
Neurology. 2008 Aug 26;71(9):670-6. doi: 10.1212/01.wnl.0000324625.00404.15.
Zotero 插件